Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|September 17, 2021
The effect of elexacaftor/tezacaftor/ivacaftor (ETI) on glycemia in adults with cystic fibrosisKevin J Scully, Peter Marchetti, Gregory S Sawicki, et al.
ERJ Open Research|August 26, 2021
1-year outcomes for lung transplantation recipients with non-alcoholic fatty liver diseaseAnil J Trindade, Tany Thaniyavarn, Nikroo Hashemi, et al.
Frontiers in Immunology|June 18, 2020
Alemtuzumab as a Therapy for Chronic Lung Allograft Dysfunction in Lung Transplant Recipients With Short TelomeresAnil J Trindade, Tany Thaniyavarn, Keri Townsend, et al.
Thorax|April 3, 2020
Mesenchymal folliculin is required for alveolar development: implications for cystic lung disease in Birt-Hogg-Dubé syndromeLing Chu, Yongfeng Luo, Hui Chen, et al.
NPJ Genomic Medicine|March 6, 2023
An intronic variant in TBX4 in a single family with variable and severe pulmonary manifestationsFrances O Flanagan, Alexander M Holtz, Sara O Vargas, et al.
Genetics in Medicine Open|December 13, 2024
Processes and outcomes from a clinical genetics e-consultation service managed by a primary care physician championBenjamin J Kerman, Carrie B L Zawatsky, Elizabeth Fieg, et al.
JHLT Open|February 2, 2026
Bronchial stenosis after lung transplant: Risk factors and clinical outcomesAntonio Coppolino, Rie Maurer, Ella Woehl, et al.
Plos Genetics|July 7, 2021
A homozygous stop-gain variant in ARHGAP42 is associated with childhood interstitial lung disease, systemic hypertension, and immunological findingsQifei Li, Michal Dibus, Alicia Casey, et al.
Med (New York, N.Y.)|February 28, 2025
A progranulin variant causing childhood interstitial lung disease responsive to anti-TNF-α biologic therapyJohn C Kennedy, Sara O Vargas, Martha P Fishman, et al.
Pageof 2